Literature DB >> 838164

Retinopathy and plasma growth hormone levels in idiopathic hemochromatosis with diabetes.

P Passa, F Rousselie, C Gauville, J Canivet.   

Abstract

In patients with idiopathic hemochromatosis, retinopathy was investigated by ophthalmoscopy and fluorescein angiography and was present in eight out of 23; this prevalence is similar to that reported in patients with diabetes aged between 30 and 60 years at onset of diabetes and with the same duration of the disease; in these eight patients retinopathy was of mild degree, with no impairment of visual acuity, fewer than 10 microaneurysms in each fundus, and no other retinal abnormatic islets directly. These studies confirm that anticholinergic drugs may be useful adjuvants in treating these patients.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 838164     DOI: 10.2337/diab.26.2.113

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  4 in total

1.  Glucagon secretion in diabetic patients with idiopathic haemochromatosis.

Authors:  P Passa; A S Luyckx; J L Carpentier; P J Lefebvre; J Canivet
Journal:  Diabetologia       Date:  1977-09       Impact factor: 10.122

2.  The GnRH test in idiopathic hemochromatosis.

Authors:  J J Altman; M Zygelman; M Roger; J Fiet; P Passa
Journal:  J Endocrinol Invest       Date:  1980 Jul-Sep       Impact factor: 4.256

3.  Proliferative retinopathy in a patient with diabetes mellitus and idiopathic haemochromatosis.

Authors:  C H Walsh; J M Malins
Journal:  Br Med J       Date:  1978-07-01

4.  Growth hormone, prolactin and thyrotrophin responses to thyrotrophin-releasing hormone in diabetic patients.

Authors:  A D Harrower
Journal:  Postgrad Med J       Date:  1980-07       Impact factor: 2.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.